Ovarian Cancer: The “Gynaecological Challenge” from Diagnostic Work-Up to Cytoreduction and Chemotherapy. Volume 2

Original price was: $ 195.00.Current price is: $ 162.00.

Ovarian Cancer: The “Gynaecological Challenge” from Diagnostic Work-Up to Cytoreduction and Chemotherapy. Volume 2

Ovarian cancer is one of the deadliest gynaecological cancers. In most cases, it is detected as an advanced tumor, since early diagnosis is challenging for most forms of the disease. Surgery and platinum-based compounds have been the mainstay of therapy for many years. The prognosis for ovarian cancer depends on the type of surgery and on the response to chemotherapy. Other regimens have little effect if the disease does not respond to platinum. However, several new therapies are emerging including bevacizumab and PARP-inhibitors, among others. This book provides a detailed body of information important to an understanding of the clinical aspects and management of such a challenging disease. The authors strive to provide the physician with insights and illustrations as well as useful tips and tricks for the everyday clinical practice. Several world-known experts in the field participated in this fruitful effort offering their knowledge and everyday experience, as well as valuable and original photos from their personal archives as well as the most recent and up-to-date guidelines in the field.

Product details

  • ASIN ‏ : ‎ B0CT3786WY
  • Publisher ‏ : ‎ Nova Science Publishers, Inc.; 1st edition (January 1, 2024)
  • Language ‏ : ‎ English
  • Hardcover ‏ : ‎ 399 pages
  • ISBN-13 ‏ : ‎ 979-8886976441

99Medical Books is offering all kind of Medical books, Medical Exams Qbank, Audio/Video CD’s and DVD’s and almost all the Medical study material.

Description

Ovarian Cancer: The “Gynaecological Challenge” from Diagnostic Work-Up to Cytoreduction and Chemotherapy. Volume 2

Ovarian cancer is one of the deadliest gynaecological cancers. In most cases, it is detected as an advanced tumor, since early diagnosis is challenging for most forms of the disease. Surgery and platinum-based compounds have been the mainstay of therapy for many years. The prognosis for ovarian cancer depends on the type of surgery and on the response to chemotherapy. Other regimens have little effect if the disease does not respond to platinum. However, several new therapies are emerging including bevacizumab and PARP-inhibitors, among others. This book provides a detailed body of information important to an understanding of the clinical aspects and management of such a challenging disease. The authors strive to provide the physician with insights and illustrations as well as useful tips and tricks for the everyday clinical practice. Several world-known experts in the field participated in this fruitful effort offering their knowledge and everyday experience, as well as valuable and original photos from their personal archives as well as the most recent and up-to-date guidelines in the field.

Product details

  • ASIN ‏ : ‎ B0CT3786WY
  • Publisher ‏ : ‎ Nova Science Publishers, Inc.; 1st edition (January 1, 2024)
  • Language ‏ : ‎ English
  • Hardcover ‏ : ‎ 399 pages
  • ISBN-13 ‏ : ‎ 979-8886976441

99Medical Books is offering all kind of Medical books, Medical Exams Qbank, Audio/Video CD’s and DVD’s and almost all the Medical study material.

Reviews

There are no reviews yet.

Be the first to review “Ovarian Cancer: The “Gynaecological Challenge” from Diagnostic Work-Up to Cytoreduction and Chemotherapy. Volume 2”

Your email address will not be published. Required fields are marked *